Prostate Cancer (cont.)
William C. Shiel Jr., MD, FACP, FACR
Dr. Shiel received a Bachelor of Science degree with honors from the University of Notre Dame. There he was involved in research in radiation biology and received the Huisking Scholarship. After graduating from St. Louis University School of Medicine, he completed his Internal Medicine residency and Rheumatology fellowship at the University of California, Irvine. He is board-certified in Internal Medicine and Rheumatology.
Dennis Lee, MD
Dr. Lee was born in Shanghai, China, and received his college and medical training in the United States. He is fluent in English and three Chinese dialects. He graduated with chemistry departmental honors from Harvey Mudd College. He was appointed president of AOA society at UCLA School of Medicine. He underwent internal medicine residency and gastroenterology fellowship training at Cedars Sinai Medical Center.
In this Article
- Prostate cancer facts
- What is the prostate gland?
- What is prostate cancer?
- Why is prostate cancer important?
- What are prostate cancer causes?
- What are prostate cancer symptoms and signs?
- What are the screening tests for prostate cancer?
- What are false positive elevations in the PSA test?
- What refinements have been made in the PSA test?
- How is prostate cancer diagnosed and graded?
- How is the staging of prostate cancer done?
- What are the treatment options for prostate cancer?
- What about prostate cancer surgery?
- What about radiation therapy for prostate cancer?
- What about hormonal treatment for prostate cancer?
- What is cryotherapy for prostate cancer?
- What is HIFU for prostate cancer?
- What is chemotherapy for prostate cancer?
- What are the differences between hormonal treatment and chemotherapy?
- What about herbal or other alternative medicine treatments for prostate cancer?
- What is active surveillance for prostate cancer?
- Can prostate cancer be prevented?
- What will be the future treatments for prostate cancer?
- Controversy in prostate cancer today
- Find a local Oncologist in your town
Controversy in prostate cancer today
While many areas are subjects of ongoing clinical study and differences of opinion, many now agree that patients with recently diagnosed prostate cancer are sometimes feeling pushed by their doctors along therapeutically aggressive and expensive paths. This argument has impacted screening recommendations, among others. It is true that many patients will be advised to have surgery by surgeons and radiation by radiation specialists and often don't know how to weigh the options put before them. It is imperative that patients be offered support and counsel by others at this time, including their primary care doctors, medical oncologists, or others with some medical expertise to help weigh the options patients have before them. More and more literature is becoming available in print and online to which patients may also be referred at this time. Such counsel can help relieve patients' anxieties and also help them to make both a sensible and potentially cost-effective decision.
For further information on prostate cancer, contact your local branch of the American Cancer Society or call 1-800-ACS2345.
Medically reviewed by Paul Oneill, MD; Board Certified Oncology, and Jay B. Zatzkin, MD American Board of Internal Medicine with subspecialty in Medical Oncology
Chang, S.S., M.C. Benson, S.C. Campbell, J. Crook, R. Dreicer, C.P. Evans, et al. "Society of Urologic Oncology Position Statement: Redefining the Management of Hormone-Refractory Prostate Carcinoma." Cancer 103.1 Jan. 1, 2005: 11-21.
Kataja, V.V., and J. Bergh. "ESMO Minimum Clinical Recommendations for Diagnosis, Treatment and Follow-up of Prostate Cancer." Ann Oncol 16.1 (2005): i34-6.
Loblaw, D.A., D.S. Mendelson, J.A. Talcott, K.S. Virgo, M.R. Somerfield, E. Ben-Josef, et al. "Initial Hormonal Management of Androgen-Sensitive Metastatic, Recurrent, or Progressive Prostate Cancer: 2006 Update of an American Society of Clinical Oncology Practice Guideline." J Clin Oncol 22.14 July 15, 2004: 2927-2941.
Zaheer, A., S.Y. Cho, and M.G. Pomper. "New Agents and Techniques for Imaging Prostate Cancer." J Nucl Med 50.9 Sept. 2009: 1387-1390.
Viewers share their comments
- Submit »
- Submit »
Get the latest treatment options.